Following distinguished scientists will deliver plenary lecture at the symposium:
Topic: Recent Developments in Strategies and Tactics Towards Complex Secondary Metabolites as enabling tools for the Study of Natural Products Biology.
Topic: Accelerator Mass Spectrometry beyond 2020: What can we expect from future AMS systems.
Topic: Use of Isotopes in Drug Design and Mechanistic Drug Disposition.
Topic: Targeted alpha therapy with Actinium 225 and Bismuth 213.
Topic: Stable Isotopes in Lung Infectious Diseases: Improved Drugs and New Breath Test Diagnostics.
The lecture time is reserved also for:
- Melvin Calvin Lecture which will be given by 2017 Malvin Calvin Award awardee
- Awardees of Journal of Labelled Compounds and Radiopharmaceuticals Award for Junior Scientists
- 2017 Outstanding Labelling Paper Awardee
Session 1 :Synthesis and application of compounds labelled by 3H.
Chairman: Jens Atzrodt (Sanofi-Aventis, ✉: email@example.com)
Session 2 :Synthesis and application of compounds labelled by 14C.
Chairman: Jon Bloom (Quotient, ✉: firstname.lastname@example.org)
Session 3 :Synthesis and application of compounds labelled with medical radionuclides.
Chairman: Ondřej Lebeda (Institute of Nuclear Physics of the CAS, ✉: email@example.com)
Session 4 :Stable isotopes of biogenic elements - chemistry of labelling and applications.
Chairman: Prof. Frank Turecek (University of Washington, ✉: firstname.lastname@example.org)
Session 5 :Preclinical and clinical studies of drug candidates supported by labelled compounds.
Chairman: Brad Maxwell (Vertex Pharmaceuticals, ✉: email@example.com)
Session 6 :Analytical methods for characterisation of labelled compounds and developments in the field of formulation and storage of compounds with high specific activity.
Chairman: Martin Sandvoss (Sanofi-Aventis, ✉: Martin.Sandvoss@sanofi.com)
Session 7 :Emerging new fields in chemistry of isotopes and in isotope techniques applications.
Chairman: William Lockley (University of Surrey, ✉: firstname.lastname@example.org)
Session 8 :Poster Session – All Subjects
Chairman: Thomas Hartung (Hoffmann La Roche, ✉: email@example.com)